Market cap
₹8 Cr
Revenue (TTM)
₹6 Cr
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 38.78 | -85.22 | -90.25 | -56.06 | -- |
| EBIT | 200.00 | -97.20 | -101.32 | -121.73 | -- |
| Net Profit | 150.00 | 104.08 | -592.00 | -200.49 | -- |
| EPS | 150.00 | 104.08 | -591.80 | -200.48 | -- |
| Book Value | -- | -- | -7.40 | -1.59 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-15 | Mar-14 |
| EBIT-Margin
| 1.22 | -- | -0.25 | -0.82 | 1.63 |
| Net Margin
| -0.64 | -- | -6.11 | -2.34 | -0.09 |
| Return on equity
| -1.60 | -- | -2.69 | -7.68 | -0.73 |
| Return on Capital
| 4.82 | -- | -- | -1.15 | 6.51 |
| Return on Assets
| -0.19 | -- | -1.24 | -1.69 | -0.18 |
| Debt to Equity (x)
| -- | -- | 0.00 | 1.11 | 1.10 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
-1.15
|
6.51
|
9.11
|
6.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-2.69
Lower than Peers by 13.55
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-2.69
|
-7.68
|
-0.73
|
3.61
|
1.54
|
|
Peer Median
|
10.86
|
--
|
--
|
--
|
--
|
ROA
-1.24
Lower than Peers by 7.98
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-1.24
|
-1.69
|
-0.18
|
1.30
|
0.42
|
|
Peer Median
|
6.74
|
--
|
--
|
--
|
--
|
EBIT Margin
-0.25
Lower than Peers by 12.94
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-0.25
|
-0.82
|
1.63
|
2.86
|
2.46
|
|
Peer Median
|
12.69
|
--
|
--
|
--
|
--
|
Net Margin
-6.11
Lower than Peers by 14.97
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-6.11
|
-2.34
|
-0.09
|
0.52
|
0.20
|
|
Peer Median
|
8.86
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
0.00
|
-1.64
|
0.07
|
0.69
|
0.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-90.25
Lower than Peers by 98.38
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-90.25
|
-62.64
|
23.76
|
42.65
|
27.69
|
|
Peer Median
|
8.14
|
--
|
--
|
--
|
--
|
EBIT Growth
-101.32
Lower than Peers by 118.56
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-101.32
|
-118.83
|
-29.27
|
65.64
|
91.11
|
|
Peer Median
|
17.24
|
--
|
--
|
--
|
--
|
Net Profit Growth
-592.00
Lower than Peers by 608.85
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-592.00
|
-908.61
|
-120.54
|
267.64
|
-38.82
|
|
Peer Median
|
16.85
|
--
|
--
|
--
|
--
|
EPS Growth
-591.80
Lower than Peers by 602.40
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-591.80
|
-908.61
|
-120.54
|
267.49
|
-81.63
|
|
Peer Median
|
10.60
|
--
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
-7.40
|
-0.73
|
3.67
|
232.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
1.11
|
1.10
|
0.82
|
1.33
|
|
Peer Median
|
0.04
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
1.10
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
1.10
|
0.82
|
0.82
|
0.60
|
0.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.71
Lower than Peers by 0.01
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
1.71
|
1.24
|
1.11
|
1.84
|
1.66
|
|
Peer Median
|
1.72
|
--
|
--
|
--
|
--
|
Quick Ratio
1.61
Higher than Peers by 0.44
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
1.61
|
1.15
|
1.08
|
1.71
|
1.46
|
|
Peer Median
|
1.17
|
--
|
--
|
--
|
--
|
Interest Coverage
-0.04
Lower than Peers by 7.91
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
-0.04
|
-0.51
|
0.97
|
1.40
|
1.16
|
|
Peer Median
|
7.86
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
380.98
Higher than Peers by 355.19
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
380.98
|
49.65
|
41.34
|
28.74
|
37.03
|
|
Peer Median
|
25.79
|
--
|
--
|
--
|
--
|
Asset Turnover
0.20
Lower than Peers by 0.46
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
0.20
|
0.72
|
2.08
|
2.49
|
2.09
|
|
Peer Median
|
0.67
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
292.59
|
117.83
|
99.82
|
119.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
17.44
|
6.36
|
11.13
|
14.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
234.09
|
78.63
|
29.10
|
30.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
75.95
|
45.55
|
81.86
|
103.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
39.90
|
--
|
--
|
--
|
--
|
Price / Book Value
0.79
Lower than Peers by 3.44
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
0.79
|
1.04
|
1.15
|
--
|
--
|
|
Peer Median
|
4.23
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.10
|
--
|
--
|
--
|
--
|
EV/EBITDA
254.05
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
254.05
|
-548.22
|
13.98
|
8.20
|
17.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
8
Lower than Peers by 7,605
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-15
|
Mar-14
|
Mar-13
|
Mar-12
|
|---|---|---|---|---|---|
|
Roselabs
|
8
|
10
|
12
|
--
|
--
|
|
Peer Median
|
7,613
|
--
|
--
|
--
|
--
|